OMEICOS Therapeutics

0 followers

‌

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Industries

Therapeutics, Health Care

Headquarters

Berlin, Germany

Employees

11-50

Links

Org chart

Robert Fischer

Co-Founder, CEO & CSO

Robert Fischer

Collapse

Simon Russell

CBO, Consultancy

Karen Uhlmann

VP of Operations & IP, Co-Founder

Edita Bade

Head of Finance & Controlling

Janine Lossie

Clinical Project Manager

Teams

Board Members and Co-Founders

7 members

Clinical and Research Team

5 members

Leadership Team

3 members

Similar companies

Fresenius Medical Care

25 followers

Alumis

1 follower

ARS Pharmaceuticals

1 follower

ViaLase

2 followers

Scalable Capital

7 followers

Foundation for Health Leadership and Innovation

3 followers

Biotrial Inc.

1 follower

DTCP

3 followers

Tacto

3 followers

Stepful

2 followers

Apollo Global Management

37 followers

Explore companies

��������